1. Home
  2. DBVT vs TBLA Comparison

DBVT vs TBLA Comparison

Compare DBVT & TBLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DBVT

DBV Technologies S.A.

HOLD

Current Price

$20.54

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Taboola.com Ltd.

TBLA

Taboola.com Ltd.

HOLD

Current Price

$3.84

Market Cap

952.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
DBVT
TBLA
Founded
2002
2007
Country
France
United States
Employees
90
2000
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
952.2M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
DBVT
TBLA
Price
$20.54
$3.84
Analyst Decision
Buy
Strong Buy
Analyst Count
7
4
Target Price
$32.04
$5.00
AVG Volume (30 Days)
234.3K
1.3M
Earning Date
04-30-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
10.26
N/A
EPS
N/A
N/A
Revenue
$5,636,000.00
N/A
Revenue This Year
$35.04
$7.63
Revenue Next Year
$2,360.78
$5.25
P/E Ratio
N/A
$42.36
Revenue Growth
35.77
N/A
52 Week Low
$7.53
$2.84
52 Week High
$26.19
$4.65

Technical Indicators

Market Signals
Indicator
DBVT
TBLA
Relative Strength Index (RSI) 49.54 72.08
Support Level $20.23 $3.06
Resistance Level $23.52 $4.20
Average True Range (ATR) 0.93 0.11
MACD -0.10 0.04
Stochastic Oscillator 35.62 84.56

Price Performance

Historical Comparison
DBVT
TBLA

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

About TBLA Taboola.com Ltd.

Taboola is a performance-based native advertising network designed to improve click-through rates and increase monetizable events for advertisers while generating yield for publisher websites. Taboola competes with Google, Amazon, and other advertising networks that display stories and products on websites. The company was founded in 2007 in Israel. It acquired Connexity, a retail advertising network, in 2021, and entered a partnership with Yahoo in 2022, in which it acquired exclusive native advertising rights over Yahoo digital properties in exchange for a 25% equity stake in the company.

Share on Social Networks: